Program intends to develop and test a vaccine against all four major parasitic worm infectio
Sabin's research on Dengue was mentioned in a New York Times article.
Novartis today announced that it has entered into a development and licensing agreement with Biological E Limited (BioE), a biopharmaceutical company based in India, for two vaccines to protect against typhoid and paratyphoid fevers. The agreement advances the Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions.
The Global Post published a write-up of the June 27th Hill hearing featuring Dr. Peter Hotez: “Calling Attention to tropical diseases on Capitol Hill”
Peter J. Hotez, president of the Sabin Vaccine Institute and dean of the new National School of Tropical Medicine at Baylor College of Medicine, addressed concerns from lawmakers about the relationship between immigration and NTDs. Hotez acknowledged that immigration may be contributing to the incidence of NTDs in the US, but that poverty played a big role.